SCHEMBL13152170

SCHEMBL13152170

CCn1c(C#Cc2cccc(F)c2)c(N)c2ccc(OC)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
DYRK1A Q13627 1/20 0.38
GRM5 P41594 4/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
SLC6A2 P23975 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KCNA5 P22460 2/20 0.37
KCNH2 Q12809 2/20 0.37
ADAM17 P78536 1/20 0.35
MAOB P27338 1/20 0.35
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13152598 0.91 CA12 (0.42) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL10249733 0.89 DYRK1A (0.40) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152163 0.88 DYRK1A (0.41) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152569 0.88 DYRK1A (0.40) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152566 0.88 GRIK2 (0.43) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152193 0.87 KDM4E (0.39) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL10249314 0.87 DYRK1A (0.41) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL10095365 0.85 MAPT (0.43) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152568 0.85 APP (0.45) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A
SCHEMBL13152171 0.83 DYRK1A (0.40) MAPTSMN1; SMN2NPSR1RXFP1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 WO disclosed